Neuro Flashcards
Valproic acid: potential adverse effects
BLACK BOX WARNINGS: pancreatitis, hepatotoxicity, fetal risk
phenytoin: potential adverse effects
gingival hyperplasia
Ototoxic meds
furosemide
erythromycin
ibuprofen
Sensorineural hearing loss is due to problems with which part of the ear?
The inner ear: Cochlea (organ of hearing), vestibular labyrinth (organ of balance)
Auditory nerve (CN VIII) or its central pathways
Conductive hearing loss is to due to problems with which part of the ear?
Outer ear: pinna, external ear canal
Middle ear: Tympanic membrane, ossicular chain (malleus, incus, stapes), and middle ear space
Weber test
Distinguishes between conductive and sensorineural hearing loss
-conductive: sound lateralizes to affected side
-sensorineural: sound lateralizes to contralateral side
Rinne test
Tests cranial nerve VIII
Evaluates conductive hearing loss
Strike a tuning fork and place it on the mastoid process
Normal: AC = 2x BC
Hearing loss: BC > AC
frontotemporal dementia: presentation
disruptions in personality and social conduct
may have primary language disorder
Lewy Body dementia: management
Medications can be used to treat agitation, hallucinations, and improve cognition or alertness, but do not decrease the rate of cognitive decline
Acetylcholinesterase inhibitors: 1st line
-donezpil, galantamine
If ineffective, atypical neuroleptics
-clozapine, quetiapine, aripiprazole
Lewy Body dementia
progressive degenerative dementia
most frequently characterized with bradykinesia and rigidity
-memory deficits
-reduced alertness
-visual hallucinations
-parkinsonian motor features: bradykinesia, resting tremor, rigidity, gait difficulty
vascular dementia: presentation
usually occurs after an infarct in a strategic location or with extensive white matter changes
does not cause visual hallucinations
CN I
Olfactory: smell
CN II
Optic: vision
CN III
Oculomotor: most EOMs, opening eyelids, pupillary constriction
CN IV
trochlear: down and inward eye movement
CN V
trigeminal: muscles of mastication; sensation of face, scalp, cornea, mucous membranes, nose
CN VI
abducens: lateral eye movement
CN VII
facial: move face, close mouth and eyes, taste (anterior 2/3), saliva and tear secretion
CN VIII
acoustic: hearing and equilibrium
CN IX
glossopharyngeal: phonation (1/3), gag reflex, carotid reflex swallowing, taste (posterior 1/3)
CN X
vagus: talking, swallowing, general sensation from the carotid body, carotid reflex
CN XI
spinal accessory: movement of the trapezius and sternomastoid muscles (shrug shoulders)
CN XII
hypoglossal: moves the tongue
CN III palsy
ptosis
dilated pupil
diplopia
eye deviated laterally and downward
Mini-mental status exam
ORArL 2, 3 RWD
Orientation to place AND time
Recognition (repeat three objects)
Attention (serial 7s counting backward from 100)
recall (ask to recall 3 objects 5 mins later)
Langauge
2 Identify names of 2 objects
3 Follow a 3-step command
Reading (e.g. Read this statement to yourself, do exactly what it says but do not say it aloud: “Close your eyes.”)
Writing
Drawing
Scoring:
- 0-17: severe dementia/delirium
- 18-23: mild dementia/delirium
- 24-30: no cognitive impairment
TIA classifications: vertebrobasilar
Occur as a result of inadequate blood flow from vertebral arteries
Presentations:
-vertigo
-ataxia
-dizziness
-visual field deficits
-weakness
-confusion
TIA classifications: carotid
due to carotid stenosis
Presentations:
-altered LOC
-aphasia, dysarthria
-weakness
-numbness
TIA: labs/Dx
CT: best for distinguishing between ischemia, hemorrhage, and tumor
MRI: best for detecting ischemic infarcts
EKG
Echocardiogram
Carotid doppler and ultrasound
Cerebral angiography
TIA: management
Aspirin
Plavix
Assess for HTN
CEA
- symptomatic low risk patients with 50-90% stenosis
- asymptomatic patients with >70% stenosis
CVA: labs/Dx
Large vessel stroke workup
-telemetry
-TEE with bubble study
-carotid imaging (US, CTA, MRA, angio)
-intracranial imaging (CTA, MRA, angio)
LP if grade I or II aneurysm to detect xanthochromia, but obtain head CT first
- contraindicated with large bleeds as brain stem herniation can be induced with rapid decompression of the subarachnoid space
CVA: Management by time of onset
<4.5 hours: tPA
- For thrombotic strokes, preferably <3 hours
<6 hours: mechanical embolectomy for all
6-24 hours: mechanical embolectomy for some
CVA: indications for ICP monitoring
Moderate: severe head injury who can’t be serially neurologically assessed
Severe head injury (GCS <8) + abnormal CT scan
Severe head injury (GCS <8) + normal CT if two of the following are present:
- Age >40
- BP <90
- Abnormal motor posturing
CVA: management for vasospasm
MAP goal 110-130 to treat cerebral vasospasm (if MCA spasms, it could interrupt blood flow to the brain and risk distal infarct)
Nimodipine (CCB) to counter vasospasm by preventing calcium from entering smooth muscle cells and causing contraction
Simple partial seizure
Common with cerebral lesions
No LOC
Rarely lasts >1 minute
Motor symptoms often start in single muscle group and spread to entire side of body
Parasthesias, flashing lights, vocalizations, hallucinations
Complex partial seizure
Common with cerebral lesions
Rarely lasts >1 minute
Motor symptoms often start in single muscle group and spread to entire side of body
Parasthesias, flashing lights, vocalizations, hallucinations
May have aura, staring, or automatisms such as lip smoking and picking at clothing
Followed by impaired level of consciousness
Absence (petit mal) seizure
Type of generalized seizure
Sudden arrest of motor activity with blank stare
Commonly discovered in children/adolescents
Begin and end suddenly
Tonic-clonic (grand mal) seizure
Type of generalized seizure
May have aura
Begins with tonic contraction (repetitive involuntary contraction of muscle), LOC, then clonic contractions (maintained involuntary contraction of muscle
Usually lasts 2-5 minutes
Incontinence may occur
Followed by postictal period
Status epilepticus
Seizure lasting >5 mins or more than 1 seizure within a 5-minute period without returning to normal level of consciousness
May occur when the patient is awake or asleep, but never regains consciousness between attacks
MEDICAL EMERGENCY
Seizures: assessment, labs/Dx
Assessment:
-presence of aura
-onset
-spread
-type of movement
-body parts involved
-pupil changes and reactivity
-duration
-loss/level of consciousness
-incontinence
-behavioral and neurological changes after cessation of seizure activity
EEG: most important test in determining classification
CT: indicated for all new onset seizures to r/o brain tumor
Seizures: management: Stabilization Phase
0-5 minutes
Stabilize: ABC’s, disability? neuro exam
Time seizure from onset
Ongoing vital signs assessment
O2 per n/c or mask; consider intubation
Continuous EKG monitoring
FSBG: if <60, IV thiamine and 50ml dextrose
Routine labs, tox screen, anticonvulsant levels
Seizures: management: Initial Therapy Phase
5-20 minutes
Choose one of the following:
- IM midazolam
- IV lorazepam
- IV diazepam
If none of these are available, choose one:
- IV pheonobarbital
- rectal diazepam
- intranasal midazolam, buccal midazolam
Seizures: management: Second Therapy Phase
20-40 minutes
Choose one of the following:
- IV fosphenytoin
- IV valproic acid
- IV keppra
If none of these are available:
- IV phenobarbital if not previously given
Seizures: management: Third Therapy Phase
40-60 minutes
Repeat second-line therapy OR
Anesthetic doses: choose one (with continuous EEG monitoring)
- thiopental
- midazolam
- pentobarbital
- propofol
Subsequent seizure prevention
Maintenance doses of long-acting anticonvulsants
-valproic acid (Depakene)
-phenobarbital (Luminal)
-phenytoin (Dilantin)
-carbamazepine (Tegretol)
-ethosuximide (Zarontin)
-primidone (Mysoline)
Myasthenia Gravis: cause
Autoimmune disorder resulting in the reduction of the number of acetylcholine receptor sites at the neuromuscular junction
Variable clinical course with remissions and exacerbations.
Myasthenia Gravis: incidence
Mostly 20-40 years old but may occur at any age
Incidence peaks in the 30s for females, 50-60s for males
More common in women
Myasthenia Gravis: S/Sx
Ptosis (common 1st complaint)
Diplopia
Dysarthria
Dysphagia
Respiratory difficulty
Extremity weakness, typically worse after exercise and better after rest
Fatigue
Sensory modalities and DTRs are normal
Myasthenia Gravis: labs/Dx
Antibodies to acetylcholine receptors
Myasthenia Gravis: management
Neurology referral
Anticholinesterase drugs block the hydrolysis of acetylcholine
- used for symptomatic improvement
- pyridostigmine bromide (Prostigmin)
Immunosuppressives
Plasmapheresis
Ventilator support during a crisis if needed
Multiple Sclerosis: Cause
Autoimmune disease marked by numbness, weakness, loss of muscle coordination, and problems with vision, speech, and bladder control
The body’s immune system attacks myelin
Variable clinical course with remissions and exacerbations
Multiple Sclerosis: Incidence
Greatest incidence is in young adults ages 20-50
Multiple Sclerosis: S/Sx
Weakness, numbness, tingling, or unsteadiness in one limb; may progress to all limbs (common 1st complaint)
Spastic paraparesis
Diplopia
Disequilibrium
Urinary urgency or hesitancy
Optic atrophy
Nystagmus